Mark K. Oki - 04 Sep 2025 Form 4 Insider Report for ACHIEVE LIFE SCIENCES, INC. (ACHV)

Reporting relationship: Chief Financial Officer
Issuer ticker: ACHV
Reported as of: 04 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Sep 2025, 17:10:00 UTC
Prior SEC filing: 19 Mar 2025
Next SEC filing: 22 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Sandra Thomson as attorney-in-fact for Mark Oki

Key filing fact

Mark K. Oki filed Form 4 for ACHIEVE LIFE SCIENCES, INC. (ACHV) on 08 Sep 2025.

Key facts

This page summarizes Mark K. Oki's Form 4 filing for ACHIEVE LIFE SCIENCES, INC. (ACHV).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Sep 2025, 17:10.

Change

Previous filing in this sequence was filed on 19 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001491847 Primary reporting owner

Oki Mark K

Relationship: Chief Financial Officer
Address: 22722 29TH DR SE, SUITE 100, BOTHELL
Signature: /s/ Sandra Thomson as attorney-in-fact for Mark Oki
Signature date: 08 Sep 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACHV transaction Derivative

Performance Restricted Stock Unit

Award

Transaction value: $0
Shares: -168,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 04 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 168,000
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents performance restricted stock units ("PRSUs") previously reported on December 9, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors.

Footnote F2

Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.

Footnote F3

Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones.